Nasal delivery of vaccines

Journal of Drug Targeting

Volumn 3, Issue 6, 1996, Pages 455-467

  Almeida, A J ^a   Alpar, H O ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Delivery systems; Liposomes; Microspheres; NALT; Nasal vaccine

Indexed keywords

ADJUVANT; ANTIGEN; LIPOSOME; NANOPARTICLE; VACCINE;

HUMAN; INTRANASAL DRUG ADMINISTRATION; LYMPHOID TISSUE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; REVIEW;

EID: 0029776393     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869609015965     Document Type: Review

References (116)

1. Abraham, E. (1992). Intranasal immunisation with bacterial polysaccharide-containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine. 10: 461-468.
2. Abraham, E. and Shah, S. (1992). Intranasal immunisation with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. Journal of Immunology. 149: 3719-3726.
3. Allison, A.C. and Gregoriadis, G. (1974). Liposomes as immunological adjuvants. Nature. 252: 252.
4. Almeida, A.J., Alpar, H.O. and Brown, M.R.W. (1992). Protein adsorbed polylactide microspheres as mucosal immunoadjuvants. Proceedings of the 6th International Conference on Pharmaceutical Technology, vol. I, pp 44-51.
5. Almeida, A.J., Alpar, H.O. and Brown, M.R.W. (1993). Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs Journal of Pharmacy and Pharmacology. 45: 198-203.
6. Alpar, H.O., Bowen, J.C. and Brown, M.R.W. (1992). Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid. International Journal of Pharmaceutics. 88: 335-344.
7. Alpar, H.O., Almeida, A.J. and Brown, M.R.W. (1994). Microspheres' absorption by the nasal mucosa of the rat. Journal of Drug Targeting. 2: 147-149.
8. Alpar, H.O., Almeida, A.J. and Brown, M.R.W. and Willamson E.D. (1994). Immune response to mucosally administered tetanus toxoid in biodegradable PLA microspheres. Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials, Nice 21: 867-868.
9. Alving, C.R., Richards, R.L., Moss, J., Alving, L.I., Clements, J.D., Shiba, T., Kotani, S., Wirts, R.A. and Hockmeyer, W.T. (1986). Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen. Vaccine. 4: 166-172.
10. Aprahamian, M., Michel, C., Humbert, W., Devissaguet, J.-P. and Damgé, C. (1987). Transmucosal passage of polyalkylcyanocrylate nanocapsules as a new drug carrier in the small intestine. Biology of the Cell. 61: 69-76.
11. Bienenstock, J. (1984). The lung as an immunologic organ. Annual Review of Medicine. 35: 49-62.
12. Bienenstock, J. (1988). The nature of immunity at mucosal surfaces - a brief review. In: Donachie, W., Griffiths, E. and Stephen, J. (eds.). Bacterial Infections of the Respiratory and Gastrointestinal Mucosae. IRL Press, Oxford, pp 9-18.
13. Bienenstock, J. and Johnston, N. (1976). A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium. Laboratory Investigation. 35: 343-348.
14. Birrenbach, G. and Speiser, P.P. (1976). Polymerised micelles and their use as adjuvants in immunology. Journal of Pharmaceutical Sciences 65: 1763-1766.
15. Bond, S.W. (1987). Intranasal administration of drugs. In: Ganderton, G. and Jones, T. (eds.). Drug Delivery to the Respiratory Tract. FC - Ellis Horwood Ltd. Chichester. pp 133-139.
16. Bowen, J.C., Alpar, O., Phillpots, R., Roberts, I.S. and Brown, M.R.W. (1990). Preliminary studies on infection by attenuated Salmonella in guinea pig and on expression of herpes simplex virus. Research in Microbiology. 141: 873-877.
17. Bowen, J.C., Alpar, O., Phillpots, R., Roberts, I.S. and Brown, M.R.W. (1995). The immune responses and protective efficacy of the skinner herpes simplex virus vaccine administered by oral and nasal routes in liposomes. Journal of Liposome Research 5: 193-214.
18. Chaicumpa, W., Parairo, J.P., New, R.C., Pongponratn, E., Ruangkunaporn, Y. Tapchaisri, P. and Chongsa-Nguan, M. (1990). Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens. Asian Pacific Journal of Allergy and Immunology. 8: 87-94.
19. Chen, W., Alley, M.R. and Manktelow, B.W. (1989). Respiratory tract-associated lymphoid tissue in conventionally raised sheep. Journal of Comparative Pathology. 101: 327-340.
20. Chen, W., Alley, M.R., Manktelow, B.W., Hopcroft, D. and Bennett, R. (1991). The potential role of the ovine pharyngeal tonsil in respiratory tract immunity: A scanning and transmission electron microscopy study of its epithelium. Journal of Comparative Pathology. 104: 47-56.
21. Childers, N.K., Denys, F.R., McGee, N.F. and Michalek, S.M. (1990). Ultrastructural study of liposome uptake by M cells of rat Peyer's patches: an oral vaccine system for delivery of purified antigen. Regional Immunology. 3: 8-16.
22. Cohen, J. (1993). Naked DNA points way to vaccines. Science. 259: 1691-1692.
23. Corry, D., Kulnarni, P. and Lipscomb, M.F. (1984). The migration of bronchioalveolar macrophages into hilar lymph nodes. American Journal of Pathology. 115: 321-328.
24. Cremaschi, D., Rossetti, C., Draghetti, M.T., Manzoni, C. and Aliverti, V. (1991). Active transport of polypeptides in rabbit nasal mucosa: possible role in the sampling of potential antigens. Pflügers Archw-European Journal of Physiology. 419: 425-432
25. Czerkinsky, C., Russel, M.W., Lycke, N., Lindblad, M. and Holmgren, J. (1989). Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infection and Immunity. 57: 1072-1077.
26. Davis, D., Davies, A. and Gregoriadis, G. (1986). Liposomes as adjuvants with immunopurified tetanus toxoid. The immune response. Immunology Letters. 14: 341-348.
27. Dertzbaugh, M.T. and Elson, C. (1993). Comparative effectiveness of cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infection and Immunity. 61: 48-55.
28. Duchêne, D. and Ponchel, G. (1993). Nasal administration: A tool for tomorrow's systemic administration of drugs. Drug Development and Industrial Pharmacy. 19: 101-122.
29. Eldridge, J.H., Gilley, R.M., Staas, J.K., Moldoveanu, Z., Meulbroek, J.A. and Tice, T.R. (1989). Biodegradable microspheres: vaccine delivery systems for oral immunisation. Current Topics in Microbiology and Immunology. 146: 59-66.
30. Eldridge, J.H., Hammond, C.J., Meulbroek, J.A., Staas, J.K., Gilley, R.W. and Tice, T.R. (1990) Controlled vaccine released in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches. Journal of Controlled Release. 11: 205-214.
31. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., McGhee, J.R., Tice, T.R. and Gilley, R.M. (1991a). Biodegradable microspheres as a vaccine delivery system. Molecular Immunology. 28: 287-294.
32. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., Tice, T.R. and Gilley, R.M. (1991b) Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infection and Immunity. 59: 2978-2986.
33. El Guink, N., Kris, R.J., Goodman-Snitkoff, G., Small Jr., P.A., Mannino, R.J. (1989). Intranasal immunisation with liposomes protects against influenza. Vaccine. 7: 147-151.
34. Fairweather, N.F., Chatfield, S.N., Makoff, A.J., Strugnell, R.A., Bester, J., Maskell, D.J. and Dougan, G. (1990). Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infection and Immunity. 58: 1323-1326.
35. Fontages, R., Robert, D., Content, Y. and Nis, G. (1980). Study of the immunogenicity of ribosomes and ribosomal RNA extracted from K. pneumoniae and S. pneumoniae. Arzneimittel-Forschung. 30: 142-172.
36. Gallinchan, W.S., Johnson, D.C., Graham, F.L. and Rosenthal, K.L. (1993). Mucosal immunity and protection after intranasal immunisation with recombinant adenovirus expressing herpes simplex virus glycoprotein B. Journal of Infectious Diseases. 168: 622-629.
37. Gilligan, C.A. and Li Wan Po, A. (1991). Oral vaccines: Design and delivery. International Joumal of Pharmaceutics. 75: 1-24.
38. Gizurarson, S., Tamura, S., Aizawa, C. and Kurata, T. (1992). Stimulation of the transepithelial flux of influenza vaccine by cholera toxin B subunit. Vaccine. 10: 101-106.
39. Greenberg, S.B., Harmson, M.W., Johnson, P.E. and Couch, R.B. (1978). Antiviral activity of intranasally applied human leucocyte interferon. Antimicrobial Agents and Chemotherapy. 14: 596-600.
40. Gregoriadis, G. (1983). Liposomes as drug carriers. Pharmacy International. 4: 33-37.
41. Gregoriadis, G. (1990). Immunological adjuvants: a role for liposomes. Immunology Today. 11: 89-97.
42. Gregson, R.L., Edmondson, N.A. and Plesch, B. (1982). Preferential uptake of soluble antigen by respiratory tract epithelium overlying bronchus-associated lymphoid tissue in the rat. Advances in Experimental Medicine and Biology. 149: 499-505.
43. Hameleers, D.M.H., Van der Ven, I., Biewenga, J. and Sminia, T. (1991). Mucosal and systemic antibody formation in the rat after intranasal administration of three different antigens. Immunology and Cell Biology: 69: 119-125.
44. Hill, A.B., Bowley, C.J., Nahrwold, M.L., Knight, P.R., Kirsh, M.M. and Denlinger, J.K. (1981). Intranasal administration of nitroglycerin. Anaesthesiology. 54: 346-34.
45. Holmgren, J. and Svennerholm, A.-M. (1988). Practical aspects of protection at mucosal surfaces: Oral vaccines against cholera and enterogenic Escherichia coli diarrhoea. In: Donachie, W., Griffiths, E. and Stephen, J. (eds.). Bacterial Infections of the Respiratory and Gastrointestinal Mucosae. IRL Press. Oxford, pp 171-188.
46. Holmgren, J., Czerkinsky, C., Lycke, N. and Svennerholm, A.-M. (1992). Mucosal immunity: Implications for vaccine development. Immunobiology. 184: 157-179.
47. Illum, L., Farraj, H. Critchley, H. and Davis, S.S. (1988) Nasal administration of gentamicin using a novel microsphere delivery system. International Journal of Pharmaceutics. 46: 261-265.
48. Ivanoff, B., André, C., Fontages, R. and Jourdan, G. (1982). Secondary immune response to oral and nasal rough mutant strains of Salmonella typhimurium. Ann. Immunol. (Inst. Pasteur). 133D: 61-70
49. Jani, P., Halbert, G.W., Langridge, J. and Florence, A.T. (1989). The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. Journal of Pharmacy and Pharmacology. 41: 809-812.
50. Jani, P., Halbert, G.W., Langridge, J. and Florence, A.T. (1990). Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. Journal of Pharmacy and Pharmacology. 42: 921-826.
51. Jani, P., Florence, A.T. and McCarthy, D.E. (1992a). Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. International Journal of Pharmaceutics. 84: 245-252.
52. Jani, P., McCarthy, D.E. and Florence, A.T. (1992b). Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose. International Journal of Pharmaceutics. 86: 239-246.
53. Jepson, M.A., Simmons, N.L., Savidge, T.C., James, P.S. and Hirst, B.H. (1993). Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells. Cell Tissue Research. 271: 399-405.
54. Junginger, H.E. (1990) Bioadhesive polymer systems for peptide delivery. Acta Pharmaceutica and Technologica. 36: 110-126.
55. Katz, J., Harmon, C.C., Buckner, G.P., Richardson, G.J., Russel, M.W. and Michalek, S.M. (1993). Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunisation with S mutans antigen I/II coupled to the B subunit of cholera toxin. Infection and Immunity. 61: 1964-1971.
56. Kreuter, J. (1991). Peroral administration of nanoparticles. Advanced Drug Delivery Reviews. 7: 71-86.
57. Kreuter, J. and Speiser, P.P. (1976). New adjuvants on a poly (methylacrylate) base. Infection and Immunity. 13: 204-210.
58. Kuper, C.F., Koornstra, P.J., Hameleers, D.H.M., Biewenga, J., Spit, B.J., Duijvestijn, A.M., Van Breda Vriesman, P.J.C. and Sminia, T. (1992). The role of nasopharyngeal lymphoid tissue. Immunology Today. 13: 219-224.
59. Langermann, S., Palaszynski, S., Sadziene, A. and Stover, C.K. (1994a). Systemic and mucosal immunity induced by BCG vector expressing outer surface protein A of Borrelia burgdorferi. Nature 372: 552-555.
60. Langermann, S., Briles, D.E., Palaszynski, S., Koenig, S. and Stover, C.K. (1994b) Protection against Pneumonococcal disease by a recombinant BCG expressing the PspA protein. Journal of Experimental Medicine 180: 2277-2286.
61. LeFevre, M.E., Vanderhoff, J.W., Laissue, J.A. and Joel, D.D. (1978) Accumulation of 2-μm latex particles in mouse Peyer's patches during chronic latex feeding. Experientia. 34: 120-122.
62. LeFevre, M.E., Hancock, D.C. and Joel, D.P. (1980). Intestinal barrier to large particles in mice. Journal of Toxicology and Environmental Health. 6: 691-704.
63. Liang, X., Lamm, M.E. and Nedrud, J.G. (1989). Cholera toxin as a mucosal adjuvant: glutaraldehyde treatment dissociates adjuvanticity from toxicity. Journal of Immunology. 143: 484-190.
64. Lim, P.L. and Rowley, D. (1982). Processing of orally absorbed immunogen. International Archives of Allergy and Applied Immunology. 68: 182-184.
65. Lycke, N. and Holmgren, J. (1986). Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens Immunology. 59: 301-308.
66. Matsuno, K., Schaffner, T., Gerber, H.A., Ruchti, C., Hess, M.W. and Cottier, H. (1983). Uptake by enterocytes and subsequent translocation into internal organs, eg, the thymus, of percoll microspheres administered per os to suckling mice. Journal of the Reticuloendothelial Society. 33: 263-273.
67. McCluggage, S.G., Low, F.N. and Zimmy, M.L. (1986). Porosity of the basement membrane overlying Peyer's patches in rats and monkeys. Gastroenterology. 91: 1128-1133.
68. McEwen, J., Levi, R., Horwitz, R.J. and Arnon, R. (1992). Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella dublin flagellin leads to partial protection in mice. Vaccine. 10: 405-411.
69. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. (1992). The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10: 75-88.
70. McKenzie, S.J. and Halsey, J.F. (1984). Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. Journal of Immunology. 133: 1818-1824.
71. Mestecky, J. and McGhee, J.R. (1987). Immunoglobulin A (IgA): Molecular and cellular interactions in IgA biosynthesis and immune response. Advances in Immunology. 40: 153-245.
72. Moxon, E.R., Smith, A.L., Averill, D.R. and Smith, D.H. (1974). Haemophilus influenzae meningitis in infant rats after intranasal inoculation. Journal of Infectious Diseases. 129: 154-162.
73. Novak, M., Moldoveanu, Z., Schafer, D.P., Mestecky, J. and Compans, R.W. (1993). Murine model of protective immunity to influenza virus. Vaccine. 11: 55-60.
74. O'Hagan, D.T. (1992). Oral delivery of vaccines: formulation and clinical pharmacokinetics considerations. Clinical Pharmacokinetics. 22: 1-10.
75. O'Hagan, D.T., Palin, K.J. and Davis, S.S. (1989). Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunisation. Vaccine. 7: 213-216.
76. O'Hagan, D.T., Jeffery, H., McGee, J.P., Davis, S.S., Rahman, D. and Challacombe, S.L. (1992). Biodegradable microparticles as oral vaccines. Proceedings of the International Symposium of Controlled Release of Bioactive Materials. 19: 118-119.
77. Oppenheim, R. (1988). Nanoparticles, solid submicron drug delivery systems. In: Hsieh, D. (ed.). Controlled Release Systems: Fabrication Technology, vol. II. CRC Press. Florida, pp 1-22.
78. Orr, N., Robin, G., Cohen, D. Arnon, R. and Lowell, G.H. (1993). Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lopopolysaccharide vaccines in animal models. Infection and Immunity. 61: 2390-2395.
79. Payne, J.M., Sansom, B.F., Garner, R.J. Thomson, A.R. and Miles, B.J. (1960). Uptake of small resin particles (1-5 μm diameter) by the alimentary canal of the calf. Nature 188: 586-587.
80. Perkins, J.C., Tucker, D.N., Knopf, H.L.S., Wenzel, R.P., Kapikian, A.Z. and Chanock, R.M. (1969). Comparison of the protective effect of neutralising antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. American Journal of Epidemiology. 90: 519-526.
81. Peters, B.A. and Allison, S.F. (1929). Intranasal immunisation against scarlet fever. Lancet. 1: 1035.
82. Pierce, N.F., Sacci Jr., J.B., Alving, C.R. and Richardson, E.C. (1984). Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin. Reviews of infectious Diseases. 6: 563-566.
83. Ray, R., Novak, M., Duncan, J.D., Matsuoka, Y. and Compans, R.W. (1993). Microencapsulated human parainfluenza virus induces a protective immune response. Journal of Infections Diseases. 167: 752-755.
84. Richardson, J., Bouchard, T. and Ferguson, C. (1976). Uptake and transport of exogenous proteins by respiratory epithelium. Laboratory Investigation. 35: 307-314.
85. Roberts, M., Cropley, I., Chatfield, S. and Dougan, G. (1993). Protection of mice against respiratory Bordetella pertussis infection by intranasal immunisation with P.69 and FHA. Vaccine. 11: 866-872.
86. Robinson, H.L., Hunt., L.A. and Webster, R.G. (1993). Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11: 957-960.
87. Rydén, L. and Edman, P. (1992). Effect of polymers and microspheres on the nasal absorption of insulin in rats. International Journal of Pharmaceutics 83: 1-10.
88. Saas, W., Dreyer, H.-P. and Seifert, J. (1990). Rapid insorption of small particles in the gut. American Journal of Gastroenterology. 48: 255-260.
89. Salit, I.E., Van Melle, E. and Tomalty, L. (1984). Experimental meningococcal infection in neonatal animals: models for mucosal invasiveness. Canadian Journal of Microbiology. 30: 1022-1029.
90. Sanchez, J., Johanson, S., Lövenadler, B., Svennerholm, A.-M. and Holmgren, J. (1990). Recombinant cholera toxin B-subunit and gene fusion proteins for oral vaccination. Research in Microbiology. 141: 971-979.
91. Shek, P.N. (1984). Applications of liposomes in immunopotentiarion. In: Muller, P.W. (ed.). Immunotoxicology. NATO ASI Series vol. G2. Springer-Verlag. Berlin. pp 103-125.
92. Spit, B.J., Hendriksen, E.G.J., Bruijntjes, J.P. and Kuper, C.F. (1989). Nasal lymphoid tissue in the rat. Cell and Tissue Research. 255: 193-198.
93. Staas, J.K., Hunt, R.E., Marx, P.A., Compans, R.W., Smith, J.F., Eldridge, J.H., Gibson, J.W., Tice, T.R. and Gilley, R.M. (1993). Mucosal immunisation using microsphere delivery systems. Proceedings of the International Symposium of Controlled Release of Bioactive Materials. 20: 63-64.
94. Stieneker, F., Kreuter, J. and Löwer, J. (1991). High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines. AIDS. 5: 431-435.
95. Sue, K.S.E., Campanale, K.M., Mendelson, L.G., Kerchner, G.A. and Gries, C.L. (1985). Nasal delivery of polypeptides. I: nasal absorption of enkephalins in rats. Journal of Pharmaceutical Sciences. 74: 394-398.
96. Sue, K.S.E., Wilson, H.C. and Campanale, K.M. (1987). Recent advances in intranasal drug delivery systems. In: Johnson, P. and Lloyd-Jones, J.G. (eds.). Drug Delivery Systems. FC-Ellis Horwood, Ltd. England. pp 224-242.
97. Talledo, E., Adams, S.F. and Zuspan, F.P. (1964). Response of pregnant human uterus to oxytocin given intranasally. Journal of the American Medical Association. 189: 348-350.
98. Tamura, S., Funato, H., Nagamine, T., Aizawa, C. and Kurata, T. (1989a). Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine. 7: 503-505.
99. Tamura, S., Samegai, Y., Kurata, H., Kikuta, K., Nagamine, T., Aizawa, C. and Kurata, T. (1989b). Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine. 7: 257-262.
100. Tamura, S., Ito, Y., Asanuma, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. and Kurata, T. (1992). Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Journal of Immunology. 149: 981-988.
101. Tenner-Rácz, K., Rácz, P., Myrvik, Q.N., Ochers, J.R. and Geister, R. (1979). Uptake and transport of horseradish peroxidase by lymphoepithelium of the bronchus associated lymphoid tissue in normal and Bacillus Calmette-Guérin immunised and challenged rabbits. Laboratory Investigation. 41: 106-115.
102. Treanor, J.J., Mattison, H.R., Dumyati, G., Yinnon, A., Erb, S., O'Brien, D., Dolin, R. and Betts, R.F. (1992). Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Annals of Internal Medicine. 117: 625-633.
103. Trudel, M., Nadon, F., Seguin, C., Brault, S., Lusignan, Y. and Lemieux, S. (1992). Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccin. Vaccine. 10: 107-112.
104. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Dwarki, V.J., Gromowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., Hawe, L.A., Leander, K.R., Martinez, D., Perry, H.C., Shiver, J.W., Montgomery, D.L., Liu, M.A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259: 1745-1749.
105. Van der Brugge-Gamelkoorn, G.J., Van der Ende, M.B. and Sminia, T. (1985). Uptake of antigens and inert particles by bronchus associated lymphoid tissue (BALT) epithelium in the rat. Cell Biology International Reports. 9: 524.
106. Volkheimer, G. and Schulz, F.H. (1968). The phenomenon of persorption. Digestion. 1: 213-218.
107. Wachsman, D., Klein, J.P., Scholler, M. and Frank, R.M (1985). Local and systemic immune response to orally administered liposome-associated soluble S. mutans cell - wall antigens. Immunology. 54: 189-193.
108. Wachsman, D., Klein, J.P., Scholler, M., Ogier, J., Ackermans, F. and Frank, R.M. (1986). Serum and salivary antibody responses in rats orally immunised with Streptococcus mutans carbohydrates protein conjugate associated with liposomes. Infection and Immunity. 52: 408-413.
109. Warshaw, A.L., Walker, W.A., Cornell, R., and Isselbacher, K.J. (1971). Small intestine permeability to macromolecules. Transmission of horseradish peroxidase into mesenteric lymph and portal blood. Laboratory Investigation. 25: 675-684.
110. Watanabe, K., Watanabe, I., Saito, Y. and Mizuhira, V. (1980). Characteristics of capillary permeability in nasal mucosa. Annals of Otology Rhinology and Laryngology. 87: 377-382.
111. Wee, S.F., Gombotz, W.R. and Fanslow, W.C. (1995). Evaluation of alginate microbeads for intranasal delivery of ovalbumin Proceedings of the 22nd International Symposium on Controlled Release of Bioactive Materials, Seattle 22: 566-567.
112. Wilson, A.D., Stokes, C.R. and Bourne, F.J. (1989). Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins - differences between mouse strains and protein antigens. Scandinavian Journal of Immunology. 29: 739-745.
113. Wolf, J.L. and Bye, W.A. (1984). The membranes epithelial (M) cells and mucosal immune system. Annual Review of Medicine 35: 95-112.
114. Wu, H.-Y. and Russel, M.W. (1993). Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with cholera toxin B subunit. Infection and Immunity. 61: 314-322.
115. Wüthrich, P. and Buri, P. (1989). Interêt de la voie transnasale pour l'administration des médicaments. I. Aspects de l'anatomie et de la physiologie nasale. Pharmaceutica Acta Helvetiae. 64: 322-331.
116. Zhou, X.H. and Li Wan Po, A. (1991). Peptide and protein drugs: II. non-parenteral routes of delivery. International Journal of Pharmaceutics. 75: 117-130.